A Study to Evaluate the Effect of Food and a Proton Pump Inhibitor on the Pharmacokinetics of VRN110755

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is a Phase 1, open-label, randomized, single-center study to evaluate the effect of food and a proton pump inhibitor (PPI) on the pharmacokinetics (PK) of VRN110755 in healthy adult participants. The primary aim of this study is to assess the impact of food and rabeprazole co-administration on the systemic exposure of VRN110755. Safety and tolerability will also be evaluated.
Epistemonikos ID: 7292ec507fdf3cb1562d4e9256320ed84909e3bc
First added on: Aug 27, 2025